PS08-002, DEV AND TESTING OF HIV PREV INTERVENTION TARGETING BLACK MSM/W
PS08-002,针对黑人 MSM/W 的 HIV 预防干预措施的开发和测试
基本信息
- 批准号:8142973
- 负责人:
- 金额:$ 29.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-30 至 2014-03-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): In the United States, Blacks continue to be disproportionately impacted by HIV/AIDS. They account for only 13% of the population, yet comprise 51% of new HIV/AIDS cases diagnoses between 2001-2004.65 Black men who have sex with men (MSM), whether they identify themselves as gay, bisexual, or heterosexual are the group most severely impacted by HIV as compared to other high-risk groups. 4 This is particularly true in Chicago, an MSA that ranked fourth among U.S. metropolitan areas in AIDS case rates among Black males in 2004 (the most recent data available).4 Male to male sexual contact is the primary mode of transmission for Black men in Chicago. In 2005, 44% of AIDS cases in Chicago were among MSM and 59% of cases among MSM were Black. The proposed study addresses the HIV prevention needs of Black bisexually-active men (BMSMW) by developing and testing a theoretically based, culturally and contextually appropriate health promotion and HIV risk reduction intervention, Project POWER. POWER, designed to be delivered through face-to-face (FtF) interactions or through the internet in real time, consists of 4 weekly sessions lasting from 60 to 90 minutes. The current application builds on prior successful collaborations between the Senior (Fernandez) and junior (Hosek) investigators, the experienced research team and TaskForce (a CBO with long history of service to BMSMW in the Chicago MSA). We will first finalize the development of POWER in the two delivery modalities and adapt the health promotion control intervention (HEALTH) for BMSMW. We will then conduct a randomized control trial (RCT) to test the acceptability, feasibility and preliminary efficacy of POWER in the two delivery modalities compared with HEALTH. Using respondent driven sampling, we will recruit 300 BMSMW and randomly assign them to one of the 3 conditions. Participants will complete behavioral assessments using ACASI and provide urine and blood specimens to test for chlamydia, gonorrhea, and syphilis at baseline, immediate post and 3 month post intervention. In addition to examining reductions in unprotected anal and/or vaginal sex episodes, we will examine contextual and cultural factors that may be associated with risk and protection in BMSMW. Throughout the project period, we will collaborate with the multi-site study team by participating in scheduled conference calls, attending meetings, completing assigned tasks, preparing manuscripts, presenting at local, national and international meetings and other work of relevance to the initiative.
描述(由申请人提供):在美国,黑人继续受艾滋病毒/艾滋病的影响不成比例。他们仅占人口的13%,但在2001-2004.65个与男性发生性关系的黑人之间占新的HIV/AIDS病例诊断的51%,无论他们是同性恋,双性恋还是异性恋者,都是与其他高风险群体相比受到HIV最严重的群体。 4在芝加哥尤其如此,芝加哥尤其如此,在2004年,黑人男性的艾滋病案例率中,MSA在美国大都市地区排名第四(最新数据)。4男性与男性性接触是芝加哥黑人男性传播的主要方式。 2005年,芝加哥的艾滋病案件中有44%在MSM中,其中59%的MSM病例是黑色。拟议的研究通过开发和测试基于理论,文化和上下文适当的健康促进以及降低艾滋病毒风险的降低干预措施,项目能力,解决黑人双性激活男性(BMSMW)的艾滋病毒预防需求。电源旨在通过面对面(FTF)互动或实时互联网交付,由40分钟到90分钟的4个每周课程组成。当前的申请基于高级(Fernandez)和Junior(Hosek)调查人员,经验丰富的研究团队和工作人员(在芝加哥MSA的BMSMW长期服务的CBO)之间的先前成功合作。我们将首先最终确定两种交付方式中的权力发展,并适应BMSMW的健康促进控制干预措施(Health)。然后,我们将进行一项随机对照试验(RCT),以测试与健康相比,功率在两种递送方式中的可接受性,可行性和初步疗效。使用受访者驱动的抽样,我们将募集300 BMSMW,并将其随机分配给3个条件之一。参与者将使用ACASI完成行为评估,并提供尿液和血液标本,以测试基线时的衣原体,淋病和梅毒,干预后立即邮政和3个月。除了检查未受保护的肛门和/或阴道性别发作的减少外,我们还将检查与BMSMW中风险和保护有关的上下文和文化因素。在整个项目期间,我们将通过参加预定的电话会议,参加会议,完成分配的任务,准备手稿,在本地,国家和国际国际会议以及其他与该计划相关的工作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
MARIA ISABEL FERN...的其他基金
A Comprehensive Community-based Strategy to Optimize the HIV Prevention and Treatment Continuum for Youth At HIV Risk, Acutely Infected and with Established HIV Infection
一项以社区为基础的综合战略,旨在优化处于艾滋病毒风险、急性感染和已确诊艾滋病毒感染的青少年的艾滋病毒预防和治疗连续性
- 批准号:1039736810397368
- 财政年份:2021
- 资助金额:$ 29.17万$ 29.17万
- 项目类别:
A Comprehensive Community-based Strategy to Optimize the HIV Prevention and Treatment Continuum for Youth At HIV Risk, Acutely Infected and with Established HIV Infection
一项以社区为基础的综合战略,旨在优化处于艾滋病毒风险、急性感染和已确诊艾滋病毒感染的青少年的艾滋病毒预防和治疗连续性
- 批准号:1062164710621647
- 财政年份:2016
- 资助金额:$ 29.17万$ 29.17万
- 项目类别:
A Comprehensive Community-based Strategy to Optimize the HIV Prevention and Treatment Continuum for Youth At HIV Risk, Acutely Infected and with Established HIV Infection
一项以社区为基础的综合战略,旨在优化处于艾滋病毒风险、急性感染和已确诊艾滋病毒感染的青少年的艾滋病毒预防和治疗连续性
- 批准号:1017421910174219
- 财政年份:2016
- 资助金额:$ 29.17万$ 29.17万
- 项目类别:
PS08-002, DEV AND TESTING OF HIV PREV INTERVENTION TARGETING BLACK MSM/W
PS08-002,针对黑人 MSM/W 的 HIV 预防干预措施的开发和测试
- 批准号:79231547923154
- 财政年份:2008
- 资助金额:$ 29.17万$ 29.17万
- 项目类别:
POWER A HEALTH PROMOTION & HIV RISK REDUCTION INTERVENTION FOR BLACK MEN
推动健康促进
- 批准号:75618067561806
- 财政年份:2008
- 资助金额:$ 29.17万$ 29.17万
- 项目类别:
Young Hispanic Men - Entre Culturas: Navigating Culture, Identity and HIV Risk
年轻西班牙裔男性 - Entre Culturas:驾驭文化、身份和艾滋病毒风险
- 批准号:73369207336920
- 财政年份:2007
- 资助金额:$ 29.17万$ 29.17万
- 项目类别:
Young Hispanic Men - Entre Culturas: Navigating Culture, Identity and HIV Risk
年轻的西班牙裔男性 - Entre Culturas:驾驭文化、身份和艾滋病毒风险
- 批准号:75040147504014
- 财政年份:2007
- 资助金额:$ 29.17万$ 29.17万
- 项目类别:
Young Hispanic Men - Entre Culturas: Navigating Culture, Identity and HIV Risk
年轻西班牙裔男性 - Entre Culturas:驾驭文化、身份和艾滋病毒风险
- 批准号:76474577647457
- 财政年份:2007
- 资助金额:$ 29.17万$ 29.17万
- 项目类别:
Young Hispanic Men - Entre Culturas: Navigating Culture, Identity and HIV Risk
年轻西班牙裔男性 - Entre Culturas:驾驭文化、身份和艾滋病毒风险
- 批准号:78745507874550
- 财政年份:2007
- 资助金额:$ 29.17万$ 29.17万
- 项目类别:
Proyecto SOL: A Risk Reduction Intervention for Hispanic MSM
Proyecto SOL:针对西班牙裔 MSM 的风险降低干预措施
- 批准号:72311457231145
- 财政年份:2006
- 资助金额:$ 29.17万$ 29.17万
- 项目类别:
相似国自然基金
新型核素偶联药载体JBN002-DOTA的开发及其在肿瘤诊疗中的应用
- 批准号:82373174
- 批准年份:2023
- 资助金额:60 万元
- 项目类别:面上项目
双胍新衍生物SMK-002阻断PKM2入核下调脂质合成抑制EMT阻止膀胱癌转移的作用和机制研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
关键挥发性有机物介导根际促生菌NRCB002定殖的根际生物学机制
- 批准号:32172673
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
双胍新衍生物SMK-002阻断PKM2入核下调脂质合成抑制EMT阻止膀胱癌转移的作用和机制研究
- 批准号:82172653
- 批准年份:2021
- 资助金额:55.00 万元
- 项目类别:面上项目
外泌体lncRNAuc002ktr.3在肺鳞癌顺铂耐药中的作用及其作为新型耐药标志物的临床价值
- 批准号:81972006
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Indication selection, patient stratification, and IND preparation for STX-002: the first-in-class LRG1 inhibitor for treatment of chronic kidney disease and immunotherapy-resistant tumours.
STX-002的适应症选择、患者分层和IND准备:用于治疗慢性肾病和免疫治疗耐药肿瘤的一流LRG1抑制剂。
- 批准号:1009258510092585
- 财政年份:2024
- 资助金额:$ 29.17万$ 29.17万
- 项目类别:Collaborative R&DCollaborative R&D
Research and Methods Core-002
研究和方法 Core-002
- 批准号:1066038210660382
- 财政年份:2023
- 资助金额:$ 29.17万$ 29.17万
- 项目类别:
RFA-DP-23-002, Improving Health Outcomes for Patients with Inflammatory Bowel Disease through Evidence-based Awareness, Referral, and Education Programs
RFA-DP-23-002,通过循证意识、转诊和教育计划改善炎症性肠病患者的健康结果
- 批准号:1076291710762917
- 财政年份:2023
- 资助金额:$ 29.17万$ 29.17万
- 项目类别:
GMP manufacturing and IND Filing of IN-002, a potent inhaled muco-trapping antibody therapy for Respiratory Syncytial Virus
IN-002 的 GMP 生产和 IND 备案,这是一种针对呼吸道合胞病毒的有效吸入粘液捕获抗体疗法
- 批准号:1076139810761398
- 财政年份:2023
- 资助金额:$ 29.17万$ 29.17万
- 项目类别: